Industrivärden, AB
Where the company increases or reduces the total number of shares or votes in the company, the company shall by law publish information regarding the change.
At the 2011 Annual General Meeting, a share conversion clause was added to Industrivärden’s articles of association. Shareholders have the right at any time to request conversion of Class A shares to Class C shares. During the month of January 2021, 73 Class A shares were converted to Class C shares.
Following the share conversion, the number of votes in the company is 283,921,527. The total number of registered shares in the company is 435,209,877, of which 267,111,711 are Class A shares and 168,098,166 are Class C shares.
Stockholm, January 29, 2021
AB INDUSTRIVÄRDEN (publ)
For further information, please contact:
Sverker Sivall, Head of Corporate Communications and Sustainability, tel. +46-8-666 64 00
This information is information that AB Industrivärden is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication by the Head of Corporate Communication and Sustainability, Sverker Sivall (tel. +46-8-666-64 00), at 10:00 a.m. CET on January 29, 2021.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanofi Winthrop Industrie17.10.2025 13:05:00 CEST | Press release
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Sanofi Winthrop Industrie17.10.2025 13:00:00 CEST | Press release
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
CrossAmerica Partners17.10.2025 12:45:00 CEST | Press release
CrossAmerica Partners to Announce Third Quarter 2025 Earnings Results on November 5
Novartis Pharma AG17.10.2025 12:37:04 CEST | Press release
Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
iFLYTEK17.10.2025 12:33:00 CEST | Press release
iFLYTEK AINOTE 2 Launches: A Game-Changer for Professional Productivity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom